Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. (300937.SZ) stock: key figures, P/E, revenue and dividend
Consumer Staples · Drug Retail · China
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 4.39 bn CNY | 4.45 bn CNY |
| Gross profit | 392.67 m CNY | 463.91 m CNY |
| Operating income | 41.99 m CNY | 44.25 m CNY |
| EBIT | 21.67 m CNY | 16.26 m CNY |
| Net income | 13.20 m CNY | -12.85 m CNY |
| Diluted EPS – continuing operations | 0.14 CNY | -0.13 CNY |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd.
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. provides omni-channel pharmaceutical distribution services in China. It offers pharmaceutical products, such as Western medicine, traditional Chinese medicine preparations, Chinese herbal medicine pieces and raw materials, food and health food, medical devices; and non-pharmaceutical products and others. The company also provides clinics, E-commerce platform operation, logistics and distribution, management consulting, warehousing, cultural and artistic exchange, drug sale and retail chain, technology promotion and application, internet hospital, other organizational management, new media operation, equipment sales, and software development services, and information technology services, as well as engages in medical research and experimental development, and online pharmaceutical retail businesses. The company was founded in 2007 and is based in Chengdu, China.
More stocks
- CapMan Oyj B (CAPMAN.HE)
- Tianjin Hi-Tech Development Co Ltd (600082.SS)
- JSL S.A (JSLG3.SA)
- CION Investment Corp (CION)
- ASURE SOFTWARE INC (ASUR)
- VERRA MOBILITY Corp (VRRM)
- Capex S.A (CAPX.BA)
- Evommune, Inc. (EVMN)
- Cabaletta Bio, Inc. (CABA)
- FRANKLIN FINANCIAL SERVICES CORP /PA/ (FRAF)
- Desiccant Technology Corporation (5292.TW)
- Daqing Huake Co Ltd (000985.SZ)
Not investment advice. All data without warranty, price as of 12.11.2026. Details in the risk notice.